In this piece, discover key talks and highlights from the World Congress on Gastrointestinal Cancer 2018.
Browsing: pancreatic cancer
Although the treatment of metastatic pancreatic adenocarcinoma across Europe generally follows the ESMO guideline, there are substantial geographic variations in treatment patterns used as first-line therapies.
Adjuvant FOLFIRINOX chemotherapy has become the standard of care for pancrearic cancer patients following the release of data from the Phase III PRODIGE 24/CCTG PA.6 trial.
Survival and glycemic control outcomes among patients with coexisting pancreatic cancer and diabetes mellitus
The objective of this study is to identify the effect of diabetes mellitus on survival of patients with pancreatic cancer and to determine whether pancreatic cancer and its treatment affect glycemic control.
The use of a new smartphone app could detect early signs of pancreatic cancer, potentially helping to diagnose pancreatic cancer whilst tumors are still treatable.
Will gemcitabine monotherapy be dethroned as the adjuvant chemotherapy in pancreatic adenocarcinoma?
In this editorial find out about the promises and limitations of gemcitabine monotherapy as an adjuvant chemotherapy in pancreatic adenocarcinoma.
Researchers have identified a panel of biomarkers in serum samples that could accurately detect the early stages of pancreatic cancer.
Listen to our exclusive interview with Philip A Philip to find out about novel agents and strategies on the horizon for pancreatic cancer.
In this review the authors discuss the most cutting-edge endoscopic techniques available in our armamentarium to diagnose, stage and treat pancreatic cancer.
Study determines that alterations in stromal collagen alignment may represent a prognostic factor in pancreatic ductal adenocarcinoma.